ARQT Arcutis Biotherapeutics, Inc.
$27.61
Arcutis Biotherapeutics, Inc. (ARQT) Earnings News
Earnings press releases, previews and reviews for Arcutis Biotherapeutics, Inc. (ARQT), newest first. Our most recent is review: Arcutis Misses Badly on Earnings as a Spending Surge Overshadows a ZORYVE Revenue Beat and Higher Guidance.
Wednesday
November 4, 2026
7:00 PM ET
Arcutis Misses Badly on Earnings as a Spending Surge Overshadows a ZORYVE Revenue Beat and Higher Guidance
Earnings Whispers · Review
Wednesday
November 4, 2026
4:00 PM ET
Arcutis Announces Third Quarter 2026 Financial Results and Provides Business Update
Tuesday
October 27, 2026
3:29 PM ET
Arcutis Must Prove Zoryve Volume Can Carry Growth as Pricing Tailwind Fades
Earnings Whispers · Preview
Wednesday
October 21, 2026
4:00 PM ET
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
Wednesday
August 5, 2026
4:00 PM ET
Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update
Wednesday
July 15, 2026
4:00 PM ET
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026